Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 14.887% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) C[C@H](NC(=O)N1CCn2c1nc1ccccc12)C(=O)NCc1ccc(F)cc1
b.) c1ccc2cc(C3N4CCCN34)ccc2c1
c.) CCOc1ccc2nc(NC(=O)/C=C/c3ccc4c(c3)OCO4)sc2c1
Answer: c. CCOc1ccc2nc(NC(=O)/C=C/c3ccc4c(c3)OCO4)sc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc2nc(NC(=O)/C=C/c3ccc4c(c3)OCO4)sc2c1
CCOc1ccc2nc(NC(=O)/C=C/c3ccc4c(c3)OCO4)sc2c1
(E)-3-(1,3-benzodioxol-5-yl)-N-(6-ethoxy-1,3-benzothiazol-2-yl)prop-2-enamide